Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Planta Med ; 88(3-04): 300-312, 2022 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-34624905

RESUMO

This study aimed to evaluate the efficacy of Norway spruce ointments on wound healing of castration wounds in piglets. This study included 95 male pigs randomly divided into five treatment groups: Norway spruce balm (Vulpuran), Norway spruce resin (Abilar), pork lard (ointment base of Vulpuran), no treatment (negative control) and antibiotic blue spray (Cyclo spray, positive control). Wound healing parameters (such as healing time, wound size, reddening of wound edges and surrounding, swelling, secretion and wound contamination), microbiological status and the haptoglobin level as an inflammation parameter were investigated. In the Norway spruce groups, some positive effects on wound healing parameters were found. In the first 6 days of treatment, Abilar or Vulpuran showed the smallest means of wound areas, and at the end of the study (day 15 + 17), the highest rates of completely closed wounds compared to the other groups. Vulpuran treatment led to significantly lower wound secretion (p = 0.003) and wound contamination (p = 0.015) than the untreated control did. Furthermore, the microbiological status was determined using MALDI-TOF-MS and partial 16S rRNA gene sequencing at different days of treatment. A comparison of the five treatment groups on day 3 revealed that Norway spruce led to the lowest rate of wounds colonised with fungi, mainly classified into genus Candida, (Abilar 77%, Vulpuran 70%) in comparison with blue spray (89%), lard (100%) and untreated control (100%). Fungi could only be detected in one of the 13 samples treated with Vulpuran on day 8, which nearly reached significance (p = 0.055).


Assuntos
Fungos , Cicatrização , Animais , Castração , Pomadas , RNA Ribossômico 16S , Suínos
2.
J Anim Physiol Anim Nutr (Berl) ; 106(2): 368-377, 2022 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-34156121

RESUMO

To our knowledge, no study has been carried out to evaluate the effects of thymol sustained administration on gut health and immune response in terms of its bioavailability in the rabbit organism. A total of 48 rabbits were randomly divided at 35 days of age into two dietary treatment groups (C/control or T/thymol at 0.025% addition). Thymol was added for 21 days and then withdrawn for 7 days. Thymol content in faeces (p < 0.001) and caecal content (p < 0.05) was significantly higher than in plasma during the thymol addition and withdrawal (2442 ± 451.4, 881.9 ± 231.3 ng/g DM and 46.2 ± 28.4 ng/ml, respectively; 149.5 ± 40.54, 45.76 ± 12.44 ng/g DM and 2.73 ± 0.45 ng/ml, respectively). Increasing of villi height to crypt depth ratio in small intestinal wall (p < 0.01), phagocytic activity in blood (p < 0.0001) and lactic acid bacteria in caecal appendix (p < 0.01) and faeces (p < 0.05) was still presented after withdrawn of thymol. The thymol at this concentration demonstrated its biological properties and was able to positively affect gut health and immune response of rabbits.


Assuntos
Microbiota , Timol , Ração Animal/análise , Animais , Disponibilidade Biológica , Dieta/veterinária , Coelhos , Timol/farmacologia
3.
Planta Med ; 86(15): 1058-1072, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-32777833

RESUMO

Viruses have a high mutation rate, and, thus, there is a continual emergence of new antiviral-resistant strains. Therefore, it becomes imperative to explore and develop new antiviral compounds continually. The search for pharmacological substances of plant origin that are effective against animal viruses, which have a high mortality rate or cause large economic losses, has garnered interest in the last few decades. This systematic review compiles 130 plant species that exhibit antiviral activity on 37 different virus species causing serious diseases in animals. The kind of extract, fraction, or compound exhibiting the antiviral activity and the design of the trial were particularly considered for review. The literature revealed details regarding plant species exhibiting antiviral activities against pathogenic animal virus species of the following families-Herpesviridae, Orthomyxoviridae, Paramyxoviridae, Parvoviridae, Poxviridae, Nimaviridae, Coronaviridae, Reoviridae, and Rhabdoviridae-that cause infections, among others, in poultry, cattle, pigs, horses, shrimps, and fish. Overall, 30 plant species exhibited activity against various influenza viruses, most of them causing avian influenza. Furthermore, 30 plant species were noted to be active against Newcastle disease virus. In addition, regarding the pathogens most frequently investigated, this review provides a compilation of 20 plant species active against bovine herpesvirus, 16 against fowlpox virus, 12 against white spot syndrome virus in marine shrimps, and 10 against suide herpesvirus. Nevertheless, some plant extracts, particularly their compounds, are promising candidates for the development of new antiviral remedies, which are urgently required.


Assuntos
Doenças dos Animais , Antivirais , Orthomyxoviridae , Plantas Medicinais , Doenças dos Animais/terapia , Animais , Antivirais/farmacologia , Bovinos , Cavalos , Extratos Vegetais/farmacologia , Suínos , Medicina Veterinária
4.
J Vet Pharmacol Ther ; 42(1): 37-44, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30242850

RESUMO

Devil's claw is used for the treatment of inflammatory symptoms and degenerative disorders in horses since many years, but without the substantive pharmacokinetic data. The pharmacokinetic parameters of harpagoside, the main active constituent of Harpagophytum procumbens DC ex Meisn., were evaluated in equine plasma after administration of Harpagophytum extract FB 8858 in an open, single-dose, two-treatment, two-period, randomized cross-over design. Six horses received a single dose of Harpagophytum extract, corresponding to 5 mg/kg BM harpagoside, and after 7 days washout period, 10 mg/kg BM harpagoside via nasogastric tube. Plasma samples at certain time points (before and 0-24 hr after administration) were collected, cleaned up by solid-phase extraction, and harpagoside concentrations were determined by LC-MS/MS using apigenin-7-glucoside as internal standard. Plasma concentration-time data and relevant parameters were described by noncompartmental model through PKSolver software. Harpagoside could be detected up to 9 hr after administration. Cmax was found at 25.59 and 55.46 ng/ml, t1/2 at 2.53 and 2.32 hr, respectively, and tmax at 1 hr in both trials. AUC0-inf was 70.46 and 117.85 ng hr ml-1 , respectively. A proportional relationship between dose, Cmax and AUC was observed. Distribution (Vz /F) was 259.04 and 283.83 L/kg and clearance (CL/F) 70.96 and 84.86 L hr-1  kg-1 , respectively. Treatment of horses with Harpagophytum extract did not cause any clinically detectable side effects.


Assuntos
Anti-Inflamatórios/farmacocinética , Glicosídeos/farmacocinética , Harpagophytum , Extratos Vegetais/farmacologia , Piranos/farmacocinética , Animais , Anti-Inflamatórios/administração & dosagem , Anti-Inflamatórios/sangue , Estudos Cross-Over , Feminino , Glicosídeos/sangue , Cavalos/sangue , Cavalos/metabolismo , Intubação Gastrointestinal/veterinária , Masculino , Extratos Vegetais/administração & dosagem , Piranos/sangue , Distribuição Aleatória
5.
Planta Med ; 76(4): 393-8, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19809971

RESUMO

In some medicinal plants a specific plant-fungus association, known as arbuscular mycorrhizal (AM) symbiosis, increases the levels of secondary plant metabolites and/or plant growth. In this study, the effects of three different AM treatments on biomass and sesquiterpenic acid concentrations in two IN VITRO propagated genotypes of valerian ( VALERIANA OFFICINALIS L., Valerianaceae) were investigated. Valerenic, acetoxyvalerenic and hydroxyvalerenic acid levels were analyzed in the rhizome and in two root fractions. Two of the AM treatments significantly increased the levels of sesquiterpenic acids in the underground parts of valerian. These treatments, however, influenced the biomass of rhizomes and roots negatively. Therefore this observed increase was not accompanied by an increase in yield of sesquiterpenic acids per plant. Furthermore, one of the two genotypes had remarkably high hydroxyvalerenic acid contents and can be regarded as a hydroxyvalerenic acid chemotype.


Assuntos
Fungos , Indenos/metabolismo , Micorrizas , Extratos Vegetais/metabolismo , Raízes de Plantas/crescimento & desenvolvimento , Sesquiterpenos/metabolismo , Valeriana/metabolismo , Biomassa , Genótipo , Rizoma , Simbiose , Valeriana/genética , Valeriana/crescimento & desenvolvimento
6.
Animals (Basel) ; 10(8)2020 Jul 22.
Artigo em Inglês | MEDLINE | ID: mdl-32707992

RESUMO

Thymol concentrations in rabbit plasma, intestinal wall (IW) and faeces were detected, and the effects of thymol application and withdrawal on biochemical, antioxidant parameters and fatty acids (FA) in blood (B) and muscle (M) were studied. Forty-eight rabbits were divided into two experimental groups (control, C and with thymol 250-mg/kg feed, T). Thymol was administered for 21 days (TA) and withdrawn for seven days (TW). Thymol in plasma correlated with that in the IW (Spearman's correlation coefficient (rs) = -1.000, p = 0.0167, TA) and was detected in faeces (TA and TW). In TA alkaline phosphatase (p = 0.0183), cholesterol (p = 0.0228), malondialdehyde (p = 0.003), glutathione peroxidase (p = 0.0177) in B and lactate dehydrogenase (M, p = 0.0411) decreased; monounsaturated FA (p = 0.0104) and α-linolenic acid (p = 0.0227) in M increased. In TW urea (p = 0.0079), docosapentaenoic acid (p = 0.0069) in M increased; linoleic acid (p = 0.0070), ∑ n-6 (p = 0.0007) in M and triglycerides decreased (B, p = 0.0317). In TA and TW, the total protein (p = 0.0025 and 0.0079), creatinine (B; p = 0.0357 and 0.0159) and oleic acid (M; p = 0.0104 and 0.0006) increased. Thymol was efficiently absorbed from the intestine and demonstrated its biological activity in blood and the muscles.

7.
Phytother Res ; 22(11): 1533-8, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18814210

RESUMO

In the present study the antimicrobial potential of various extracts from 12 medicinal plants has been investigated in vitro on multiple antibiotic resistant pathogens and some selected protozoa isolated from poultry. The initial examination was performed on E. coli (n = 10) using disc and agar well diffusion assays. Only two plants, Peganum harmala (seeds) and Eucalyptus globulus (leaves) showed positive responses. The active extracts were also investigated against an additional 19 bacteria and the clonal cultures of three protozoa (Histomonas meleagridis, Tetratrichomonas gallinarum and Blastocystis sp.). Only Peganum harmala was found to inhibit the growth of all bacteria and protozoa at 0.38-1.55 mg/mL and 0.63-1.65 mg/mL, respectively. To investigate the potential role of alkaloids in crude extracts of Peganum harmala, four known beta-carbolin alkaloids were quantified and their antimicrobial activity was compared using a microdilution assay. Harmaline was found to be in the highest concentration followed by harmine and harmalol, whereas harmane could not be detected. The activity of the pure alkaloids was in the order harmane > harmaline > harmalol > or = harmine for all bacteria, while for protozoa, it was different depending on the microorganism. It is concluded that Peganum harmala or its alkaloids could probably be used for the control of antibiotic resistant isolates of bacteria as well as protozoa.


Assuntos
Bactérias/efeitos dos fármacos , Carbolinas/farmacologia , Eucariotos/efeitos dos fármacos , Harmalina/análogos & derivados , Harmina/análogos & derivados , Peganum/química , Animais , Antibacterianos/farmacologia , Antiprotozoários/farmacologia , Galinhas/microbiologia , Resistência a Medicamentos , Harmalina/farmacologia , Harmina/farmacologia , Testes de Sensibilidade Microbiana , Testes de Sensibilidade Parasitária , Fitoterapia , Extratos Vegetais/farmacologia , Plantas Medicinais/química
8.
Neuropsychopharmacology ; 32(8): 1661-8, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17192774

RESUMO

Numerous findings indicate alterations in brain serotonin systems in obsessive-compulsive disorder (OCD). We investigated the in vivo availability of thalamus-hypothalamus serotonin transporters (SERT) in patients with DSM-IV OCD who displayed prominent behavioral checking compulsions (OC-checkers). Four hours after injection of [(123)I]-2beta-carbomethoxy-3beta-(4-iodophenyl)tropane ([(123)I]-beta-CIT), single photon emission computed tomography (SPECT) scans were performed in 24 medication-free non-depressed OC-checkers and 24 age- and gender-matched healthy controls. For quantification of brain serotonin transporter availability, a ratio of specific to non-displaceable [(123)I]-beta-CIT brain binding was used (V''(3)=(thalamus and hypothalamus-cerebellum)/cerebellum). Drug-free non-depressed OC-checkers showed an 18% reduced brain serotonin transporter availability in the thalamus and hypothalamus, as compared with healthy control subjects (1.38+/-0.19 vs 1.69+/-0.21; p<0.001). There was a strong negative correlation between severity of OC symptomatology (Y-BOCS scores) and SERT availability (r=-0.80; p<0.001). Moreover, we found a significant positive correlation between illness duration and serotonin transporter availability (r=0.43; p<0.05). This first report of significantly reduced [(123)I]-beta-CIT binding in the thalamus-hypothalamus region in OC-checkers suggests reduced brain serotonin transporter availability, which is more pronounced with increased severity of OC symptomatology and short duration of illness. The results provide direct evidence for an involvement of the serotonergic system in the pathophysiology of OCD.


Assuntos
Hipotálamo/diagnóstico por imagem , Transtorno Obsessivo-Compulsivo , Proteínas da Membrana Plasmática de Transporte de Serotonina/metabolismo , Tálamo/diagnóstico por imagem , Tomografia Computadorizada de Emissão de Fóton Único/métodos , Adulto , Estudos de Casos e Controles , Cocaína/análogos & derivados , Cocaína/farmacocinética , Feminino , Humanos , Hipotálamo/efeitos dos fármacos , Hipotálamo/metabolismo , Masculino , Pessoa de Meia-Idade , Transtorno Obsessivo-Compulsivo/diagnóstico , Transtorno Obsessivo-Compulsivo/diagnóstico por imagem , Transtorno Obsessivo-Compulsivo/patologia , Ligação Proteica/efeitos dos fármacos , Compostos Radiofarmacêuticos/farmacocinética , Estatísticas não Paramétricas , Tálamo/efeitos dos fármacos , Tálamo/metabolismo
9.
Z Naturforsch C J Biosci ; 61(3-4): 165-70, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16729571

RESUMO

Separation and isolation of the two main compounds suaveolol and methyl suaveolate from leaves of chichinguaste (Hyptis suaveolens Poit., Lamiaceae) could be achieved by means of repeated column chromatography and repeated preparative thin layer chromatography. Their chemical structures were approved by MS, 1H NMR, 13C NMR and 2D-NMR experiments. The anti-inflammatory activity of the two compounds was tested for the first time as inhibition of croton oil-induced dermatitis of the mouse ear. Suaveolol and methyl suaveolate showed nearly the same dose-dependent topical anti-inflammatory activity, only two to three times lower than that of the reference drug indomethacin. The anti-inflammatory properties of these compounds could contribute to the antiphlogistic activity of extracts of Hyptis species and confirm the rational use of Hyptis suaveolens extracts in dermatological diseases.


Assuntos
Anti-Inflamatórios não Esteroides/isolamento & purificação , Diterpenos/isolamento & purificação , Hyptis/química , Animais , Cromatografia em Camada Fina , Dermatite/tratamento farmacológico , El Salvador , Espectroscopia de Ressonância Magnética , Espectrometria de Massas , Camundongos , Fitoterapia
10.
Parasite ; 23: 41, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27627637

RESUMO

Disposal of organic plant wastes and by-products from the food or pharmaceutical industries usually involves high costs. In the present study, 42 samples derived from such by-products were screened in vitro against Cryptosporidium parvum, a protozoan parasite that may contaminate drinking water and cause diarrhoea. The novel bioassay was previously established in the microtitre plate format. Human ileocaecal adenocarcinoma (HCT-8) cell cultures were seeded with C. parvum oocysts and parasite development was monitored by an indirect fluorescent antibody technique (IFAT) and microscopic assessment for clusters of secondary infection (CSI). Minimum inhibitory concentrations (MICs) and potential detrimental effects on the host cells were determined. An ethanolic extract from olive (Olea europaea) pomace, after oil pressing and phenol recovery, reproducibly inhibited C. parvum development (MIC = 250-500 µg mL(-1), IC50 = 361 (279-438) µg mL(-1), IC90 = 467 (398-615) µg mL(-1)). Accordingly, tyrosol, hydroxytyrosol, trans-coniferyl alcohol and oleuropein were selected as reference test compounds, but their contributions to the observed activity of the olive pomace extract were insignificant. The established test system proved to be a fast and efficient assay for identifying anti-cryptosporidial activities in biological waste material and comparison with selected reference compounds.


Assuntos
Cryptosporidium parvum/efeitos dos fármacos , Eliminação de Resíduos de Serviços de Saúde/métodos , Olea/química , Compostos Fitoquímicos/farmacologia , Adenocarcinoma/patologia , Bioensaio , Indústria Farmacêutica , Indústria Alimentícia , Humanos , Neoplasias do Íleo/patologia , Valva Ileocecal/patologia , Eliminação de Resíduos de Serviços de Saúde/normas , Extratos Vegetais/farmacologia , Plantas Medicinais/química , Células Tumorais Cultivadas
11.
Biol Psychiatry ; 66(12): 1115-22, 2009 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-19717141

RESUMO

BACKGROUND: To our knowledge, no studies have investigated the predictive value of central serotonin transporter (SERT) availability for treatment response to serotonin reuptake inhibitors (SSRIs) in patients with obsessive-compulsive disorder (OCD). This study used brain imaging to examine the relationship between pretreatment SERT availability and transporter occupancy as well as treatment response by sertraline in patients displaying prominent behavioral checking compulsions (OC checkers). METHODS: Single photon emission computed tomography (SPECT) was used to measure thalamic-hypothalamic SERT availability with [(123)I]-2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane in 28 nondepressed OC checkers at baseline and after 14 weeks of treatment with sertraline (175 mg daily). SERT availability was correlated with OC severity and treatment response as assessed with the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). Associations between individual transporter occupancies and clinical parameters were investigated. RESULTS: 1) Correlation analyses between thalamic-hypothalamic SERT availability and OC severity showed significant negative associations at baseline and after treatment with sertraline. 2) Pretreatment SERT availability correlated significantly with both transporter occupancy and treatment response; in addition, a positive association was found between transporter occupancy and treatment response directly. 3) Using multivariate statistical models, the data demonstrated that higher pretreatment SERT availability significantly predicted higher occupancy rates as well as better treatment response 14 weeks later. CONCLUSIONS: Higher pretreatment thalamic-hypothalamic SERT availability may predict both higher occupancy rates and better treatment response to sertraline. The data suggest a strong connection between transporter occupancy and treatment response.


Assuntos
Diencéfalo/metabolismo , Transtorno Obsessivo-Compulsivo , Inibidores Seletivos de Recaptação de Serotonina/uso terapêutico , Proteínas da Membrana Plasmática de Transporte de Serotonina/metabolismo , Sertralina/uso terapêutico , Adulto , Cocaína/análogos & derivados , Diencéfalo/diagnóstico por imagem , Diencéfalo/efeitos dos fármacos , Vias de Administração de Medicamentos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Transtorno Obsessivo-Compulsivo/diagnóstico por imagem , Transtorno Obsessivo-Compulsivo/tratamento farmacológico , Transtorno Obsessivo-Compulsivo/patologia , Ligação Proteica/efeitos dos fármacos , Compostos Radiofarmacêuticos , Inibidores Seletivos de Recaptação de Serotonina/farmacologia , Sertralina/farmacologia , Estatística como Assunto , Tomografia Computadorizada de Emissão de Fóton Único/métodos , Adulto Jovem
12.
Neuropsychopharmacology ; 33(13): 3126-34, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18354388

RESUMO

To the authors' knowledge there is as of yet no study demonstrating in vivo alterations in human serotonin transporters (SERT) during clomipramine treatment in patients with obsessive-compulsive disorder. The only study in which SERT binding has been investigated in obsessive-compulsive disorder (OCD) patients before and after treatment is a small pilot study by Stengler-Wenzke et al (2006), who treated five OCD patients with citalopram. In the study at hand, we measured transporter availability in the thalamus-hypothalamus with [(123)I] beta-CIT single photon emission computed tomography (SPECT) in 24 patients with DSM-IV OCD. All patients displayed prominent behavioral checking compulsions (OC-checkers). At baseline and upon medication after 12 weeks of treatment with clomipramine (150 mg daily) 24 non-depressed OC-checkers underwent a SPECT measurement of brain SERT availability using [(123)I]-2beta-carbomethoxy-3beta-(4-iodophenyl)tropane. For quantification of brain serotonin transporter availability, a ratio of specific to non-displaceable [(123)I] beta-CIT brain binding was used (BP(ND)=(thalamus and hypothalamus-cerebellum)/cerebellum). The SERT availability was compared between baseline and after treatment and correlated with severity of OC symptomatology and treatment response as assessed with the Yale-Brown Obsessive Compulsive Scale (Y-BOCS). After treatment with clomipramine patients showed a 48% reduced brain serotonin transporter availability in the thalamus-hypothalamus, as compared with values at baseline (0.72+/-0.12 vs 1.39+/-0.18, p<0.001). Correlations between brain SERT availability and OC symptomatology (Y-BOCS scores) revealed significantly negative associations both at baseline and after treatment (r=-0.46; p<0.05 and r=-0.53; p<0.01 respectively). These data suggest that the SERT availability values could be considered a biological indicator of disease severity. Moreover, in search of predictors we found that higher pretreatment SERT availability significantly predicted better treatment response 12 weeks later (B=14.145+/-4.514; t=3.133; p=0.005). These results provide further support for an important role of alterations in serotonergic neurons in the pathophysiology of OCD.


Assuntos
Clomipramina/farmacologia , Hipotálamo/efeitos dos fármacos , Transtorno Obsessivo-Compulsivo/tratamento farmacológico , Proteínas da Membrana Plasmática de Transporte de Serotonina/efeitos dos fármacos , Serotonina/metabolismo , Tálamo/efeitos dos fármacos , Adulto , Ligação Competitiva/efeitos dos fármacos , Ligação Competitiva/fisiologia , Citalopram , Regulação para Baixo/efeitos dos fármacos , Regulação para Baixo/fisiologia , Feminino , Humanos , Hipotálamo/diagnóstico por imagem , Hipotálamo/metabolismo , Radioisótopos do Iodo , Masculino , Pessoa de Meia-Idade , Transtorno Obsessivo-Compulsivo/diagnóstico por imagem , Transtorno Obsessivo-Compulsivo/metabolismo , Proteínas da Membrana Plasmática de Transporte de Serotonina/metabolismo , Inibidores Seletivos de Recaptação de Serotonina/farmacologia , Tálamo/diagnóstico por imagem , Tálamo/metabolismo , Tomografia Computadorizada de Emissão de Fóton Único , Resultado do Tratamento , Adulto Jovem
13.
Berl Munch Tierarztl Wochenschr ; 119(5-6): 238-43, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16729471

RESUMO

The objective of the study at hand was to investigate within the framework of a pilot project the preference of weaner pigs for either an ad libitum standard feed with thyme or oregano herb as flavouring additive or an ad libitum standard feed without any herbal additive. Thyme or oregano herbs or a combination of both were offered in two different concentrations each (1% and 0.1%) as additive (experimental diets) in standard diet in comparison to the latter without herbal additive (control diet) free of choice. The dosage of the two herbs in terms of total essential oil(s) in the feeds used in the study was 0.02% or 0.002% (v/w), which was equivalent to 1% or 0.1% herbs in the mixture, respectively. A Latin square according to Williams (1949) was used with 6 groups in order to record possible differences in feed intake. All experimental diets aside from that mixed with 0.1% thyme herb were, in comparison to the control diet, significantly less ingested. Where the weanling was given the choice, it did not choose feed with any flavouring additive. Further studies aimed at assessing the use of herbs as aroma additive in the form of a choice experiment are recommended.


Assuntos
Dieta/veterinária , Preferências Alimentares , Origanum , Suínos/fisiologia , Thymus (Planta) , Ração Animal/normas , Animais , Ingestão de Alimentos , Comportamento Alimentar/fisiologia , Aditivos Alimentares , Cromatografia Gasosa-Espectrometria de Massas/métodos , Origanum/química , Projetos Piloto , Óleos de Plantas/química , Thymus (Planta)/química , Desmame , Aumento de Peso/fisiologia
14.
Berl Munch Tierarztl Wochenschr ; 119(1-2): 50-4, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16450709

RESUMO

Thymi Herba (Thymus vulgaris, rubbed) was given as feed additive to weanling piglets. 3 concentrations (0.1%, 0.5%, 1%) were tested against a control group. Rectal swabs were collected weekly and were sent in for bacterial testing. The shedding of haemolysing E. coli was evaluated. There was no significant difference in the shedding of haemolysing E. coli between the 4 groups. Neither was there a difference in the distribution of the various serotypes. Thymol was detected in the blood plasma in all thyme groups. The increase in thymol level with greater amounts of thyme herb was significant. Three days after withdrawal of the feed additive no thymol levels were detected. The study results did not reveal any effects on haemolysing E. coli in the gut.


Assuntos
Anti-Infecciosos/sangue , Infecções por Escherichia coli/veterinária , Fitoterapia/veterinária , Extratos Vegetais/uso terapêutico , Doenças dos Suínos/tratamento farmacológico , Timol/sangue , Thymus (Planta)/química , Animais , Animais Recém-Nascidos , Suplementos Nutricionais , Relação Dose-Resposta a Droga , Infecções por Escherichia coli/tratamento farmacológico , Distribuição Aleatória , Suínos , Resultado do Tratamento , Desmame
15.
Berl Munch Tierarztl Wochenschr ; 118(11-12): 495-501, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16318274

RESUMO

The aim of the study was to test Thymi herba (1.66% v/w essential oil with 39% p-cymene and 32% thymol) in the rearing period of piglets as feed additive. Therefore, two feeding trials were performed with piglet groups ranging from 17 to 22 animals each. Either 10 g of Thymi herba/kg feed (Thymi herba group), 10 mg flavophospholipol/kg feed (flavophospholipol group) or nothing (control group) was added to the animals' feed. No significant differences in the performance parameter daily weight gain among any groups were recorded. No differences concerning feed efficiency or isolation of haemolytic E. coli serotypes were shown. In addition, the antibacterial activity of the essential oil of Thymi herba against 39 haemolytic E. coli isolates from the same weaners was investigated in vitro by disk diffusion, minimum inhibitory concentration and bactericidal concentration testing. In contrast to the feeding results, the essential oil of the thyme batch fed showed antibacterial activity against all haemolytic E. coli investigated. This interesting antibacterial potential of Thymi herba prompts further investigations as to its value as feed additive.


Assuntos
Ração Animal , Escherichia coli/efeitos dos fármacos , Óleos de Plantas/farmacologia , Suínos/crescimento & desenvolvimento , Thymus (Planta)/química , Animais , Animais Recém-Nascidos , Escherichia coli/crescimento & desenvolvimento , Feminino , Masculino , Testes de Sensibilidade Microbiana/veterinária , Óleos de Plantas/administração & dosagem , Distribuição Aleatória , Suínos/microbiologia , Desmame
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA